Clinical trial
New Study on the Prevalence of COPD in Spain EPI-Scan-II Study
NCT03028207 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Study on the Prevalence of COPD in Spain EPI-Scan-II Study
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 9, 2017
- Completion date
- March 1, 2019
- Enrollment
- 9,362 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.